Type of sarcoma: Desmoplastic Small Round Cell Tumours
Full title: A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
Age: 12 months to 29 years
Phase: 1/2
Locations: Royal Manchester Children’s Hospital, The Christie, University College London Hospital, Royal Marsden Hospital
This study aims to find out how safe and effective ramucirumab is in combination with other chemotherapy in the treatment of relapsed, recurrent, or refractory desmoplastic small round cell tumour (DSRCT) in children and young adults.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
